Annexon Biosciences
Annexon Biosciences Raises $125M in Series D
Quick Facts
Annexon Biosciences Raises $125M in Series D
Annexon Biosciences has successfully raised $125M in a Series D at a $750M valuation led by GV, Alta Partners, Omega Funds, Cowen Healthcare Investments, Redmile Group.
Company Overview
Annexon Biosciences is a Biotech company headquartered in 180 Kimball Way, South San Francisco, CA 94080, founded in 2011 with 150+ employees.
Classical complement pathway inhibitors
Fundraising Details
- Amount Raised: $125M
- Round Type: Series D
- Valuation: $750M
- Date: 2024-08-18
- Investors: GV, Alta Partners, Omega Funds, Cowen Healthcare Investments, Redmile Group
About Annexon Biosciences
Classical complement pathway inhibitors The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 180 Kimball Way, South San Francisco, CA 94080
- Founded: 2011
- Team Size: 150+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Annexon Biosciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Annexon Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $750M valuation marks an important milestone for Annexon Biosciences, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Annexon Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-08-18. For more information about Annexon Biosciences, visit their headquarters at 180 Kimball Way, South San Francisco, CA 94080.
About the Author
Related Company Reports
Anthropic Raises $2B in Series D
Anthropic, a AI/ML company based in San Francisco, CA, has raised $2B in Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.
xAI Raises $6B in Series C
xAI, a AI/ML company based in San Francisco, CA, has raised $6B in Series C at a $40B valuation led by Sequoia Capital, a16z, Valor Equity.
Adept AI Raises $350M in Series B
Adept AI, a AI/ML company based in San Francisco, CA, has raised $350M in Series B at a $1B valuation led by General Catalyst, Spark Capital, Addition.